DK336188D0
(da)
*
|
1988-06-20 |
1988-06-20 |
Nordisk Gentofte |
Propeptider
|
US6875589B1
(en)
*
|
1988-06-23 |
2005-04-05 |
Hoechst Aktiengesellschaft |
Mini-proinsulin, its preparation and use
|
US5514646A
(en)
*
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
US5126249A
(en)
*
|
1989-05-09 |
1992-06-30 |
Eli Lilly And Company |
Enzymatic removal of a protein amino-terminal sequence
|
DK155690D0
(da)
*
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
DK10191D0
(da)
*
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
US5304473A
(en)
*
|
1991-06-11 |
1994-04-19 |
Eli Lilly And Company |
A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5504188A
(en)
*
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
AU3562195A
(en)
*
|
1994-10-04 |
1996-04-26 |
Novo Nordisk A/S |
Preparations containing aspb28 human insulin and nicotinamide
|
US5597893A
(en)
*
|
1994-10-31 |
1997-01-28 |
Eli Lilly And Company |
Preparation of stable insulin analog crystals
|
US5631347A
(en)
*
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
CN1069649C
(zh)
*
|
1996-01-25 |
2001-08-15 |
中国科学院上海生物化学研究所 |
[b9谷氨酸,b10门冬氨酸]人胰岛素
|
US5948751A
(en)
*
|
1996-06-20 |
1999-09-07 |
Novo Nordisk A/S |
X14-mannitol
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
BR9813111A
(pt)
|
1997-10-24 |
2000-08-15 |
Lilly Co Eli |
Composições de insulina insolúveis
|
WO1999024071A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Alza Corporation |
Method for decreasing self-association of polypeptides
|
CO4970787A1
(es)
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
US6933272B1
(en)
|
1998-09-22 |
2005-08-23 |
Erik Helmerhorst |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
AUPP609198A0
(en)
*
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US7022674B2
(en)
*
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
EP1265630B1
(de)
|
2000-03-24 |
2006-06-07 |
Genentech, Inc. |
Verwendung von insulin zur behandlung von knorpelkrankheiten
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7638618B2
(en)
|
2001-02-20 |
2009-12-29 |
Sanofi-Aventis Deutschland Gmbh |
Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
|
US7202059B2
(en)
|
2001-02-20 |
2007-04-10 |
Sanofi-Aventis Deutschland Gmbh |
Fusion proteins capable of being secreted into a fermentation medium
|
WO2002067969A2
(en)
*
|
2001-02-21 |
2002-09-06 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7601688B2
(en)
*
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
DE10227232A1
(de)
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
CN1247616C
(zh)
*
|
2002-07-19 |
2006-03-29 |
上海中科生龙达生物技术(集团)有限公司 |
新的单体胰岛素,药物组合物及其制法
|
US7193035B2
(en)
|
2002-10-29 |
2007-03-20 |
Sanofi-Aventis Deutschland Gmbh |
Crystals of insulin analogs and processes for their preparation
|
ATE405660T1
(de)
|
2003-06-17 |
2008-09-15 |
Sembiosys Genetics Inc |
Verfahren zur insulinproduktion in pflanzen
|
WO2005012347A2
(en)
|
2003-08-05 |
2005-02-10 |
Novo Nordisk A/S |
Novel insulin derivatives
|
ES2402592T3
(es)
|
2003-08-05 |
2013-05-07 |
Novo Nordisk A/S |
Nuevos derivados de insulina
|
SI3300721T1
(sl)
|
2003-11-20 |
2019-07-31 |
Novo Nordisk A/S |
Peptidne formulacije, ki vsebujejo propilen glikol in ki so optimalne za proizvodnjo in uporabo v napravah za injiciranje
|
EP1692168B1
(de)
|
2003-12-03 |
2011-07-20 |
Novo Nordisk A/S |
Einzelketteninsulin
|
CN1909930B
(zh)
|
2004-01-21 |
2015-12-16 |
诺和诺德医疗保健公司 |
转谷氨酰胺酶介导的肽的接合
|
CN103223160B
(zh)
|
2004-07-19 |
2015-02-18 |
比奥孔有限公司 |
胰岛素-低聚物共轭物,制剂及其用途
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
US20080171695A1
(en)
|
2005-02-02 |
2008-07-17 |
Novo Nordisk A/S |
Insulin Derivatives
|
ES2438145T3
(es)
|
2005-02-02 |
2014-01-16 |
Novo Nordisk A/S |
Nuevos derivados de insulina
|
EP1862174A1
(de)
*
|
2005-03-02 |
2007-12-05 |
Ajinomoto Co., Inc. |
Mittel zur hemmung der insulin-polymer-bildung
|
ES2368500T3
(es)
|
2005-08-16 |
2011-11-17 |
Novo Nordisk A/S |
Método para producir polipéptidos de insulina maduros.
|
MY146082A
(en)
|
2005-09-14 |
2012-06-29 |
Sanofi Aventis Deutschland |
Cleavage of precursors of insulins by a variant of trypsin
|
EP1969004B1
(de)
|
2005-12-28 |
2011-08-10 |
Novo Nordisk A/S |
Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen
|
EP1991576B1
(de)
|
2006-02-27 |
2010-09-29 |
Novo Nordisk A/S |
Insulinderivate
|
US20090054305A1
(en)
|
2006-03-15 |
2009-02-26 |
Novo Nordisk A/S |
Mixtures of Amylin and Insulin
|
ES2548393T3
(es)
|
2006-05-09 |
2015-10-16 |
Novo Nordisk A/S |
Derivado de insulina
|
US8796205B2
(en)
|
2006-05-09 |
2014-08-05 |
Novo Nordisk A/S |
Insulin derivative
|
JP2009539778A
(ja)
*
|
2006-06-08 |
2009-11-19 |
ダイアベコア メディカル インコーポレイテッド |
インスリンオリゴマー誘導体
|
WO2008034881A1
(en)
|
2006-09-22 |
2008-03-27 |
Novo Nordisk A/S |
Protease resistant insulin analogues
|
ES2563038T3
(es)
|
2007-04-30 |
2016-03-10 |
Novo Nordisk A/S |
Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
|
MX2009012789A
(es)
|
2007-06-01 |
2009-12-10 |
Novo Nordisk As |
Composiciones farmaceuticas no acuosas estables.
|
EP2514406A1
(de)
|
2007-06-01 |
2012-10-24 |
Novo Nordisk A/S |
Spontan dispergierbare Vorkonzentrate mit einem Peptidwirkstoff in einem festen oder halbfesten Träger
|
CN101677947B
(zh)
|
2007-06-13 |
2013-07-17 |
诺沃-诺迪斯克有限公司 |
包含胰岛素衍生物的药物制剂
|
PT2203181T
(pt)
|
2007-10-16 |
2018-05-10 |
Biocon Ltd |
Uma composição farmacêutica sólida para administração por via oral e o seu processo de fabrico
|
KR101656107B1
(ko)
|
2007-11-20 |
2016-09-08 |
암브룩스, 인코포레이티드 |
변형된 인슐린 폴리펩티드 및 이의 용도
|
KR20100111682A
(ko)
|
2008-01-09 |
2010-10-15 |
사노피-아벤티스 도이칠란트 게엠베하 |
극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체
|
CN101970477B
(zh)
|
2008-03-14 |
2014-12-31 |
诺沃-诺迪斯克有限公司 |
蛋白酶稳定的胰岛素类似物
|
DK2910570T3
(en)
|
2008-03-18 |
2017-01-30 |
Novo Nordisk As |
Protease-stabilized acylated insulin analogues.
|
DE102008053048A1
(de)
|
2008-10-24 |
2010-04-29 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DK2349324T3
(en)
*
|
2008-10-17 |
2017-12-11 |
Sanofi Aventis Deutschland |
COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
|
DE102008051834A1
(de)
|
2008-10-17 |
2010-04-22 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102009038210A1
(de)
|
2009-08-20 |
2011-03-03 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
BRPI0919946A2
(pt)
|
2008-10-30 |
2016-02-16 |
Novo Nordisk As |
tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
|
TW201113032A
(en)
|
2009-07-06 |
2011-04-16 |
Sanofi Aventis Deutschland |
Slow-acting insulin preparations
|
TW201105346A
(en)
*
|
2009-07-06 |
2011-02-16 |
Sanofi Aventis Deutschland |
Heat-stable and vibration-stable insulin preparations
|
DK2451437T3
(en)
|
2009-07-06 |
2017-02-13 |
Sanofi Aventis Deutschland |
Aqueous INSULIN PREPARATIONS CONTAINING METHIONIN
|
UA108475C2
(uk)
|
2009-07-31 |
2015-05-12 |
Санофі-Авентіс Дойчланд Гмбх |
Композиція інсуліну тривалої дії
|
MX2012001399A
(es)
|
2009-07-31 |
2012-03-21 |
Sanofi Aventis Deutschland |
Profarmacos que comprenden un conjugado de insulina-conector.
|
PE20121316A1
(es)
|
2009-11-13 |
2012-10-05 |
Sanofi Aventis Deutschland |
Composicion farmaceutica que comprende un agonista de glp-1 y metionina
|
PT2498802E
(pt)
|
2009-11-13 |
2015-04-13 |
Sanofi Aventis Deutschland |
Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
|
BR112012028766A2
(pt)
|
2010-05-10 |
2017-06-13 |
Novo Nordisk As |
processo para a preparação de complexos de insulina e zinco
|
US8735539B2
(en)
|
2010-08-17 |
2014-05-27 |
Ambrx, Inc. |
Relaxin polypeptides comprising non-naturally encoded amino acids
|
HUE031181T2
(en)
|
2010-08-30 |
2017-06-28 |
Sanofi Aventis Deutschland |
Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
|
EP2438930A1
(de)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrug mit einem exendinbindenden Konjugat
|
DK2632478T3
(da)
|
2010-10-27 |
2019-10-07 |
Novo Nordisk As |
Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
|
KR20130139297A
(ko)
|
2010-10-27 |
2013-12-20 |
노보 노르디스크 에이/에스 |
다양한 주사 간격으로 투여된 인슐린 주사를 이용한 진성 당뇨병의 치료
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
EP2750699B1
(de)
|
2011-08-29 |
2015-07-22 |
Sanofi-Aventis Deutschland GmbH |
Pharmazeutische kombination zur verwendung bei der glykämischen kontrolle von patienten mit typ- 2-diabetes
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
CN104788556A
(zh)
|
2011-12-15 |
2015-07-22 |
上海恒瑞医药有限公司 |
人胰岛素类似物及其酰化衍生物
|
AU2013255880B2
(en)
|
2012-05-01 |
2017-07-20 |
Novo Nordisk A/S |
Pharmaceutical composition
|
WO2013173923A1
(en)
|
2012-05-25 |
2013-11-28 |
Diamedica, Inc. |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
EP2854841B1
(de)
|
2012-06-04 |
2017-02-22 |
Diamedica Inc. |
Kallikrein-1-glycosylierungsisoformen aus menschlichem gewebe
|
AU2013346624B2
(en)
|
2012-11-13 |
2018-08-09 |
Adocia |
Quick-acting insulin formulation including a substituted anionic compound
|
WO2014093696A2
(en)
|
2012-12-12 |
2014-06-19 |
Massachusetts Institute Of Technology |
Insulin derivatives for diabetes treatment
|
CA2889165A1
(en)
|
2012-12-19 |
2014-06-26 |
Wockhardt Limited |
A stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
US20150246129A1
(en)
|
2012-12-26 |
2015-09-03 |
Wockhardt Limited |
Pharmaceutical composition
|
KR20140088837A
(ko)
*
|
2013-01-03 |
2014-07-11 |
한미약품 주식회사 |
N-말단 전하가 변형된 인슐린 분비 펩티드 유도체
|
TWI780236B
(zh)
|
2013-02-04 |
2022-10-11 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
WO2014177623A1
(en)
|
2013-04-30 |
2014-11-06 |
Novo Nordisk A/S |
Novel administration regime
|
JP2016531847A
(ja)
|
2013-09-30 |
2016-10-13 |
ウォックハート リミテッド |
医薬組成物
|
RS57004B1
(sr)
|
2013-10-07 |
2018-05-31 |
Novo Nordisk As |
Novi derivat analoga insulina
|
MX2016008979A
(es)
|
2014-01-09 |
2016-10-04 |
Sanofi Sa |
Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
|
CN105899191B
(zh)
|
2014-01-09 |
2020-06-16 |
赛诺菲 |
胰岛素类似物和/或胰岛素衍生物的稳定化不含甘油的药物制剂
|
RU2016132340A
(ru)
|
2014-01-09 |
2018-02-14 |
Санофи |
Стабилизированные фармацевтические составы на основе инсулина аспарта
|
AR099569A1
(es)
*
|
2014-02-28 |
2016-08-03 |
Novo Nordisk As |
Derivados de insulina y los usos médicos de estos
|
CN104017809A
(zh)
*
|
2014-06-05 |
2014-09-03 |
山东省农业科学院生物技术研究中心 |
改造的人Insulin蛋白表达基因及表达方法
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
FI3229828T3
(fi)
|
2014-12-12 |
2023-05-29 |
Sanofi Aventis Deutschland |
Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio
|
TW201630622A
(zh)
|
2014-12-16 |
2016-09-01 |
美國禮來大藥廠 |
速效胰島素組合物
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
UY36870A
(es)
*
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
CN105440125B
(zh)
*
|
2015-11-25 |
2019-09-24 |
华润昂德生物药业有限公司 |
地特胰岛素或其类似物的制备方法
|
GB201607918D0
(en)
|
2016-05-06 |
2016-06-22 |
Arecor Ltd |
Novel formulations
|
BR112019005637A2
(pt)
|
2016-09-23 |
2019-07-30 |
Hanmi Pharm Ind Co Ltd |
análogos da insulina com afinidade reduzida para o receptor de insulina e seu uso
|
US20190282667A1
(en)
|
2016-09-29 |
2019-09-19 |
Arecor Limited |
Novel formulations
|
DK3554534T3
(da)
|
2016-12-16 |
2021-08-23 |
Novo Nordisk As |
Farmaceutisk sammensætning omfattende insulin
|
EP3592377A4
(de)
|
2017-03-09 |
2021-02-17 |
Diamedica Inc. |
Darreichungsformen von gewebekallikrein 1
|
CN110536899B
(zh)
|
2017-03-23 |
2023-12-12 |
韩美药品株式会社 |
对胰岛素受体具有降低的亲和力的胰岛素类似物复合物及其用途
|
GB201707188D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
GB201707187D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
GB201707189D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
AU2018275545B2
(en)
|
2017-06-01 |
2021-02-04 |
Eli Lilly And Company |
Rapid-acting insulin compositions
|
EP3773472A1
(de)
|
2018-04-04 |
2021-02-17 |
Arecor Limited |
Medizinisches infusionspumpensystem zur abgabe einer insulinverbindung
|
EP3773473A1
(de)
|
2018-04-04 |
2021-02-17 |
Arecor Limited |
Medizinisches infusionspumpensystem zur abgabe einer insulinverbindung
|
CA3094237A1
(en)
|
2018-04-04 |
2019-10-10 |
Arecor Limited |
Medical infusion pump system for the delivery of an insulin compound
|
JP2021524464A
(ja)
|
2018-05-24 |
2021-09-13 |
江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司Jiangsu Hengrui Medicine Co., Ltd. |
組換えヒトインスリンまたはそのアナログの前駆体の調製方法
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
BR112022013150A2
(pt)
|
2019-12-30 |
2023-02-28 |
Gan & Lee Pharmaceuticals Co Ltd |
Derivado da insulina
|
WO2021136303A1
(zh)
|
2019-12-30 |
2021-07-08 |
甘李药业股份有限公司 |
长效glp-1化合物
|
GB202004814D0
(en)
|
2020-04-01 |
2020-05-13 |
Arecor Ltd |
Novel formulations
|
CN114075275A
(zh)
*
|
2020-08-17 |
2022-02-22 |
成都奥达生物科技有限公司 |
一种长效胰岛素类似物
|
CN115493919B
(zh)
*
|
2022-11-21 |
2023-04-07 |
保定佳瑞源生物芯片有限公司 |
一种c肽和胰岛素检测试剂盒的校准品稀释液
|